• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算机断层扫描的骨骼分割用于多发性骨髓瘤骨受累的定量 PET 指标测量。

Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.

机构信息

School of Medical Sciences.

Physics Institute.

出版信息

Nucl Med Commun. 2020 Apr;41(4):377-382. doi: 10.1097/MNM.0000000000001165.

DOI:10.1097/MNM.0000000000001165
PMID:32058446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7077955/
Abstract

PURPOSE

Quantifications in nuclear medicine are occasionally limited by the lack of standardization for defining volumes of interest (VOIs) on functional images. In the present article, we propose the use of computed tomography (CT)-based skeletal segmentation to determine anatomically the VOI in order to calculate quantitative parameters of fluorine 18 fluorodeoxyglucose (F-FDG) PET/CT images from patients with multiple myeloma.

METHODS

We evaluated 101 whole-body F-FDG PET/CTs of 58 patients with multiple myeloma. An initial subjective visual analysis of the PET images was used to classify the bone involvement as negative/mild, moderate, or marked. Then, a fully automated CT-based segmentation of the skeleton was performed on PET images. The maximum, mean, and SD of the standardized uptake values (SUVmax, SUVmean, and SDSUV) were calculated for bone tissue and compared with the visual analysis.

RESULTS

Forty-five (44.5%), 32 (31.7%), and 24 (23.8%) PET images were, respectively, classified as negative/mild, moderate, or marked bone involvement. All quantitative parameters were significantly related to the visual assessment of bone involvement. This association was stronger for the SUVmean [odds ratio (OR): 10.52 (95% confidence interval (CI), 5.68-19.48); P < 0.0001] and for the SDSUV [OR: 5.58 (95% CI, 3.31-9.42); P < 0.001) than for the SUVmax [OR: 1.01 (95% CI, 1.003-1.022); P = 0.003].

CONCLUSION

CT-based skeletal segmentation allows for automated and therefore reproducible calculation of PET quantitative parameters of bone involvement in patients with multiple myeloma. Using this method, the SUVmean and its respective SD correlated better with the visual analysis of F-FDG PET images than SUVmax. Its value in staging and evaluating therapy response needs to be evaluated.

摘要

目的

在核医学中,由于缺乏定义功能图像中感兴趣区(VOI)体积的标准化方法,定量分析有时会受到限制。在本文中,我们提出使用基于计算机断层扫描(CT)的骨骼分割来从解剖学上确定 VOI,以便计算多发性骨髓瘤患者氟 18 氟脱氧葡萄糖(F-FDG)PET/CT 图像的定量参数。

方法

我们评估了 58 例多发性骨髓瘤患者的 101 例全身 F-FDG PET/CT。首先对 PET 图像进行主观视觉分析,将骨受累分为阴性/轻度、中度或重度。然后,对 PET 图像进行全自动基于 CT 的骨骼分割。计算骨组织的标准化摄取值最大值(SUVmax)、平均值(SUVmean)和标准差(SDSUV),并与视觉分析进行比较。

结果

45 例(44.5%)、32 例(31.7%)和 24 例(23.8%)PET 图像分别被归类为阴性/轻度、中度或重度骨受累。所有定量参数与骨受累的视觉评估均显著相关。SUVmean 与骨受累的视觉评估相关性更强[优势比(OR):10.52(95%置信区间(CI),5.68-19.48);P<0.0001],SDSUV 与骨受累的视觉评估相关性也更强[OR:5.58(95% CI,3.31-9.42);P<0.001],而 SUVmax 与骨受累的视觉评估相关性较弱[OR:1.01(95% CI,1.003-1.022);P=0.003]。

结论

基于 CT 的骨骼分割允许自动且可重复地计算多发性骨髓瘤患者骨骼受累的 PET 定量参数。使用该方法,SUVmean 及其相应的 SD 与 F-FDG PET 图像的视觉分析相关性优于 SUVmax。其在分期和评估治疗反应中的价值需要进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/9bf57fb89e75/nmc-41-377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/ff0f4c44d68d/nmc-41-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/6a4ff74a030c/nmc-41-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/9bf57fb89e75/nmc-41-377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/ff0f4c44d68d/nmc-41-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/6a4ff74a030c/nmc-41-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea09/7077955/9bf57fb89e75/nmc-41-377-g003.jpg

相似文献

1
Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.基于计算机断层扫描的骨骼分割用于多发性骨髓瘤骨受累的定量 PET 指标测量。
Nucl Med Commun. 2020 Apr;41(4):377-382. doi: 10.1097/MNM.0000000000001165.
2
Proposal for a Quantitative F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma.用于评估多发性骨髓瘤骨受累程度的定量 F-FDG PET/CT 代谢参数的提案。
Sci Rep. 2019 Nov 11;9(1):16429. doi: 10.1038/s41598-019-52740-2.
3
Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma.骨受累程度:18F-FDG PET/CT 定量评价在多发性骨髓瘤疗效监测中的应用。
Nucl Med Commun. 2021 Dec 1;42(12):1375-1381. doi: 10.1097/MNM.0000000000001470.
4
Bone marrow segmentation and radiomics analysis of [F]FDG PET/CT images for measurable residual disease assessment in multiple myeloma.基于[F]FDG PET/CT 图像的骨髓分割和放射组学分析在多发性骨髓瘤中评估可测量残留疾病。
Comput Methods Programs Biomed. 2022 Oct;225:107083. doi: 10.1016/j.cmpb.2022.107083. Epub 2022 Aug 24.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma.18F-FDG PET/CT 图像变异系数和纹理分析预测多发性骨髓瘤患者的预后。
Ann Hematol. 2024 Sep;103(9):3713-3721. doi: 10.1007/s00277-024-05905-7. Epub 2024 Jul 24.
7
The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.FDG PET/CT 在多发性骨髓瘤患者初始分期和骨髓累及中的价值。
Skeletal Radiol. 2011 Jul;40(7):843-7. doi: 10.1007/s00256-010-1088-9. Epub 2011 Jan 13.
8
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.多发性骨髓瘤患者基线18F-FDG PET/CT检查结果与骨髓中表达CD38和CD138的骨髓瘤细胞及临床参数之间的相关性
Turk J Haematol. 2018 Aug 3;35(3):175-180. doi: 10.4274/tjh.2017.0372. Epub 2018 May 28.
9
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.正电子发射断层扫描/计算机断层扫描研究多发性骨髓瘤使用 (18)F-FDG 和 (18)F-NaF:分布模式和示踪剂药代动力学的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1343-53. doi: 10.1007/s00259-014-2721-y. Epub 2014 Feb 22.
10
Radiomics analysis of bone marrow biopsy locations in [F]FDG PET/CT images for measurable residual disease assessment in multiple myeloma.基于[F]FDG PET/CT 图像骨髓活检部位的影像组学分析在多发性骨髓瘤中评估可测量残留疾病。
Phys Eng Sci Med. 2023 Jun;46(2):903-913. doi: 10.1007/s13246-023-01265-0. Epub 2023 May 8.

引用本文的文献

1
Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images.评估Skellytour用于从全身CT图像中自动分割骨骼
Radiol Artif Intell. 2025 Mar;7(2):e240050. doi: 10.1148/ryai.240050.
2
Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.用于多发性骨髓瘤定量评估的成像和人工智能(AI)的最新进展。
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):208-229. doi: 10.62347/NLLV9295. eCollection 2024.
3
Current Status and Future of Artificial Intelligence in MM Imaging: A Systematic Review.

本文引用的文献

1
Proposal for a Quantitative F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma.用于评估多发性骨髓瘤骨受累程度的定量 F-FDG PET/CT 代谢参数的提案。
Sci Rep. 2019 Nov 11;9(1):16429. doi: 10.1038/s41598-019-52740-2.
2
Deep learning for segmentation of 49 selected bones in CT scans: First step in automated PET/CT-based 3D quantification of skeletal metastases.深度学习在 CT 扫描中对 49 块选定骨骼的分割:基于 PET/CT 的骨骼转移全自动 3D 定量的第一步。
Eur J Radiol. 2019 Apr;113:89-95. doi: 10.1016/j.ejrad.2019.01.028. Epub 2019 Feb 1.
3
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.
人工智能在骨髓瘤成像中的现状与未来:一项系统综述。
Diagnostics (Basel). 2023 Nov 2;13(21):3372. doi: 10.3390/diagnostics13213372.
4
Systematic Review of Tumor Segmentation Strategies for Bone Metastases.骨转移瘤分割策略的系统评价
Cancers (Basel). 2023 Mar 14;15(6):1750. doi: 10.3390/cancers15061750.
5
Modern imaging techniques for monitoring patients with multiple myeloma.用于监测多发性骨髓瘤患者的现代成像技术。
Med Pharm Rep. 2022 Oct;95(4):377-384. doi: 10.15386/mpr-2215. Epub 2022 Oct 27.
6
Metabolic Volume Measurements in Multiple Myeloma.多发性骨髓瘤的代谢容积测量
Metabolites. 2021 Dec 16;11(12):875. doi: 10.3390/metabo11120875.
7
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.骨转移是可测量的:全身磁共振成像和正电子发射断层扫描的作用。
Front Oncol. 2021 Nov 19;11:772530. doi: 10.3389/fonc.2021.772530. eCollection 2021.
8
99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.99mTc- 美罗昔单抗 SPECT/CT 和 18F-FDG-PET/CT 在新诊断的多发性骨髓瘤中的表现相似,但成像模式不同。
Nucl Med Commun. 2020 Oct;41(10):1081-1088. doi: 10.1097/MNM.0000000000001259.
一线治疗多发性骨髓瘤的 PET 中期分析:IMAJEM 研究中 FDG 摄取患者的 ΔSUVmax 的预后价值。
Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1.
4
CT-based tissue segmentation to assess knee joint inflammation and reactive bone formation assessed by F-FDG and F-NaF PET/CT: Effects of age and BMI.基于CT的组织分割以评估经F-FDG和F-NaF PET/CT检测的膝关节炎症和反应性骨形成:年龄和体重指数的影响
Hell J Nucl Med. 2018 May-Aug;21(2):102-107. doi: 10.1967/s002449910801. Epub 2018 Jul 12.
5
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?在弥漫性大B细胞淋巴瘤中,是否存在测量基线代谢肿瘤体积的最佳方法?
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1463-1464. doi: 10.1007/s00259-018-4005-4. Epub 2018 Apr 12.
6
Baseline PET as prognostic marker for Hodgkin?基线正电子发射断层扫描作为霍奇金淋巴瘤的预后标志物?
Blood. 2018 Jan 4;131(1):3-4. doi: 10.1182/blood-2017-11-812958.
7
Towards enhanced PET quantification in clinical oncology.迈向临床肿瘤学中增强型正电子发射断层显像(PET)定量分析
Br J Radiol. 2018 Jan;91(1081):20170508. doi: 10.1259/bjr.20170508. Epub 2017 Nov 22.
8
Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.肿瘤 PET 研究中部分容积校正的影响:系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2105-2116. doi: 10.1007/s00259-017-3775-4. Epub 2017 Aug 4.
9
AN AUTOMATIC 3D CT/PET SEGMENTATION FRAMEWORK FOR BONE MARROW PROLIFERATION ASSESSMENT.一种用于骨髓增殖评估的自动三维CT/PET分割框架。
Proc Int Conf Image Proc. 2016 Sep;2016:4126-4130. doi: 10.1109/ICIP.2016.7533136. Epub 2016 Aug 19.
10
Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.F-FDG PET/CT 在多发性骨髓瘤和其他浆细胞疾病的诊断和管理中的作用:国际骨髓瘤工作组的共识声明。
Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.